Cargando…
CRISPR/Cas9 Ablated BCL11A Unveils the Genes with Possible Role of Globin Switching
PURPOSE: Fetal hemoglobin (HbF) upregulation is a mitigating factor in β-hemoglobinopathies therapy like β-thalassemia and sickle cell diseases. Finding molecular mechanisms and the key regulators responsible for globin switching could be helpful to develop effective ways to HbF upregulation. In our...
Autores principales: | Movahedi Motlagh, Fatemeh, Soleimanpour‐Lichaei, Hamid Reza, Shamsara, Mehdi, Etemadzadeh, Azadeh, Modarressi, Mohammad Hossein |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tabriz University of Medical Sciences
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10676543/ https://www.ncbi.nlm.nih.gov/pubmed/38022811 http://dx.doi.org/10.34172/apb.2023.074 |
Ejemplares similares
-
Antiproliferative effects of AAV-delivered CRISPR/Cas9-based degradation of the HPV18-E6 gene in HeLa cells
por: Noroozi, Zahra, et al.
Publicado: (2022) -
Expression analysis data of BCL11A and γ-globin genes in KU812 and KG-1 cell lines after CRISPR/Cas9-mediated BCL11A enhancer deletion
por: Khosravi, Mohammad Ali, et al.
Publicado: (2019) -
CRISPR-Cas9 interrogation of a putative fetal globin repressor in human erythroid cells
por: Chung, Jennifer E., et al.
Publicado: (2019) -
CRISPR/Cas9-mediated β-globin gene knockout in rabbits recapitulates human β-thalassemia
por: Yang, Yi, et al.
Publicado: (2021) -
Deletion of transcription factor binding motifs using the
CRISPR/spCas9 system in the β-globin LCR
por: Kim, Yea Woon, et al.
Publicado: (2017)